The initial dose of inebilizumab-cdon is 300 mg, administered in an intravenous infusion, followed 2 weeks later by a second 300 mg intravenous infusion. After these two treatments, a single 300 ...

We also see risks in Baxter’s product lines, particularly IV solutions, nutritional products, and generic injectables that face significant quality-control issues that contribute to the firm’s ...

Expert Rev Resp Med. 2009;3(5):539-548. Studies evaluating the use of fluoroquinolones in the treatment of AECB often include elderly patients, but they are seldom in the majority. For example, a ...